Table 2:

Summary of treatment options, complication related to treatment, and angiographic and clinical outcomes

Patient No.TreatmentStent Type and Size (mm)ComplicationsImmediate AOFollow-up AO at 6–12 MonthsFollow-up MRS
1SPAAVE S670 4.0 × 24NoneIncompleteIncomplete (stable)1
2SPAAVE S670 3.5 × 30NoneCompleteComplete1
3SACAVE S670 3.5 × 24NoneCompleteComplete0
4SPA*AVE S670 3.0 × 9, 3.0 × 12NoneIncompleteComplete1
5SPA*AVE S670 3.0 × 12, 3.5 × 12NoneIncompleteComplete0
6SPAAVE S670 4.0 × 30NoneIncompleteIncomplete (stable)1
7SPAAVE S670 3.0 × 24NoneIncompleteIncomplete (stable)0
8SPAAVE Microdrive 3.5 × 24NoneIncompleteIncomplete (stable)1
9SACBS Neuroform 3.5 × 15NoneIncompleteIncomplete (unstable)2
10SACBS Neuroform 4.0 × 20NoneNear completeComplete1
11SACBS Neuroform 4.0 × 20NoneIncompleteComplete0
12SPA*AVE Microdrive 3.0 × 12, 3.5 × 12NoneIncompleteComplete1
13SPA*JOSTENT Flexmaster 2.75 × 19AVE Microdrive 2.75 × 24Temporary vasospasmIncompleteIncomplete (stable)1
14SPAAVE Microdrive 3.5 × 24NoneNear completeND1
  • Note:—AO indicates angiographic outcome; MRS, modified Rankin Scale; SPA, stent placement alone; SAC, stent-assisted coiling; AVE, Arterial Vascular Engineering; BS, Boston Scientific; ND, not done.

  • * Double stent method.